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Abstract
Cytomegalovirus (CMV) is the most frequent cause of congenital infection all over the world. Its prevalence ranges from 
0.2 to 2.2%. Transmission from children to their pregnant mothers is a well-known risk factor, particularly if they attend a 
childcare centre. This study aims to compare the prevalence of CMV congenital infection (CMV_CI) in Portugal (Lisbon) 
between two studies, performed respectively in 2019 and 2020. In the 2019 study, performed in two hospitals, we found a 
0.67% CMV_CI prevalence, using a pool strategy previously tested with saliva samples. In the 2020 study, using the same 
pool approach in four hospitals (the previous and two additional), and based on 1277 samples, the prevalence was 0.078%.
Conclusion: The close temporal coincidence with COVID-19 lockdown suggests that these measures may have had a 
significant impact on this reduction, although other explanations cannot be ruled-out.
What is Known:
• Cytomegalovirus is the leading cause of congenital infection.
• Behavioural measures decrease cytomegalovirus seroconversion in pregnant women.
What is New:
• From 2019 to 2020 there was a significant reduction in the prevalence of congenital CMV infection.
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Introduction
Cytomegalovirus (CMV) is an endemic virus, ubiquitous, 
species-specific for humans and member of the Herpesviridae 
family. This virus is the major cause of congenital infection 
disease worldwide. In utero transmission occurs in a range 
from 0.2 to 2.2%, having a negative impact in morbidity and 
mortality [1].
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When primoinfection occurs in pregnant women, the prob-
ability of transmission to the foetus varies between 30 and 
40%., with a higher risk of foetal disease when maternal infec-
tion occurs in the first 16 weeks. Not all congenitally infected 
children are symptomatic. In fact, just 10–15% will present 
symptoms, but 10 to 15% of the infants with no symptoms at 
birth will develop late sequels in the first five years of life, such 
as hearing loss, neurological, motor and visual impairment, 
among others [2]. Congenital CMV is now the major infectious 
cause of sensorineural hearing loss and neurodevelopmental 
abnormalities in infants born in developed countries [3].
Among young children with congenital infection, CMV 
shedding is lower among infants less than 1-year-old, but uni-
formly high among 1- and 2-year-old children. Thereafter, the 
shedding declines progressively, maintaining relatively high 
among 3–4-year-olds [4]. There are some reports that confirm 
the relation between high prevalence of CMV and day-care 
centers (DCC) [5]. In fact, children in large day-care group fre-
quently acquire CMV infections from other children, and they 
will shed CMV in urine and saliva for extended periods of time 
as well. As a result of this, approximately 30% of mothers with 
a cytomegalovirus-infected child younger than 2 years old can 
seroconvert within 1 year after their child attending DCC [6].
Results from a few studies showed that behavioural meas-
ures, such as, body fluids contact avoidance from young chil-
dren, reduced CMV seroconversion in pregnant women. These 
measures include avoiding contact with saliva when kissing 
young children, not sharing food, drinks or utensils used by 
them, or washing hands with soap and water for 15–20 s after 
changing nappies/diapers, feeding a young child, or wiping a 
young child’s nose or saliva [3].
Another prevention strategy would be the vaccination 
against CMV. However, despite vaccine development is far 
advanced, with several candidate vaccines being already 
tested, vaccination is not yet available [7].
The effects of the COVID-19 lockdown on decreasing inci-
dence of various communicable diseases in children have been 
discussed recently, but congenital CMV was not addressed [8]. 
Therefore, the aim of our study was to compare the 2020 prev-
alence of the congenital infection in four Portuguese hospitals 
(using a screening program with a pool strategy previously 
tested with saliva samples) [9], with the prevalence found in a 
2019 cohort, before the pandemic period [10].
Material and methodology
Population
The study population of the current project included 1277 
Portuguese newborns aged between one day and 10 days. 
They were born in Hospital CUF Descobertas (n = 349), 
Hospital Vila Franca de Xira (n = 301), Hospital S. Francisco 
Xavier – CHLO (n = 380) and Hospital CUF Porto (n = 247). 
The samples were collected between June 3rd and Novem-
ber  11th, 2020. All newborns from these four hospital units 
were included, except when parental permission could not 
be obtained.
Samples
Saliva samples were collected using breakable rod rayon 
swabs (FLmedical, Torreglia, Italy), and was always carried 
out before breastfeeding or at least one hour after the last 
meal. The swab was packaged in a 3-mL tube with 750-μL 
RPMI medium (Life Technologies, Paisley, UK). After col-
lection, the tubes were stored at 4 °C until processing. When 
a positive result was obtained with a saliva sample, a urine 
sample was collected in the two first weeks of life to confirm 
congenital infection. These were collected using paediatric 
urine collection bags, then placed in 50-mL flasks and stored 
at 4 °C until processing.
All samples were sent to the laboratory of microbiology 
associated to Infection Unit of the Faculdade de Ciências 
Médicas|Nova Medical School (FCM|NMS) for processing.
Sample processing
Sample processing is detailed elsewhere [9, 10]. Briefly, 
pools were prepared mixing 20 μL of each 10 saliva samples 
in a 1.5 mL Eppendorf tube. Genomic DNA was extracted 
using the Purelink Genomic DNA commercial kit (Invit-
rogen, Carlsbad, USA), according to the manufacturer’s 
instructions and stored at −20 °C until use. HCMV DNA 
was amplified and detected by qPCR on the Applied Bio-
systems 7500 Fast Real-Time PCR System (Applied Bio-
systems, Foster City, USA) using an “in-house” method 
with 100% sensitivity and specificity when compared with 
individual samples.
Previous study
The details of the previous study are described elsewhere 
[10]. Briefly, the study was conducted for eight months 
(between October 2018 and May 2019), and involved 1492 
newborns, aged between one day and two weeks, from Hos-
pital CUF Descobertas (n = 748) and at Hospital Vila Franca 
de Xira (n = 744). There were 10 confirmed cases, corre-
sponding to a prevalence of congenital CMV infection in 
the two participant hospitals of 0.67%.
Statistical methods
– Confidence interval for proportions, using exact binomial 
method, for each study.
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– 95% Confidence intervals for the difference between two 
proportions, using two different approaches: (1) Nor-
mal distribution; (2) based on Newcombe combination 
method [11].
Results
In the current study (2020), we grouped 1277 saliva samples 
into 129 pools of 10 samples each. Of these pools, 127 tested 
negative and two positives. After individual testing of each 
sample in the two positive pools, two positive saliva samples 
were identified.
Confirmatory urine samples showed that only one of the 
newborns had congenital infection, which represents an 
overall prevalence of 0.078%.
Table 1 presents the punctual estimates and confidence 
intervals for both studies independently and comparison 
between them. We can observe a decrease of CMV_CI 
prevalence between 2019 and 2020, considering punctual 
estimate, from 0.67 to 0.078% in 2019 (more than 8 times 
higher than 2020). Looking to interval estimation for the dif-
ference between independent proportions, and based on the 
two different approaches, both intervals limits are negative, 
meaning that there is evidence that difference in CMV_CI 
prevalence is statistically significant.
In the 2020 study, and when considering only the results 
of the same two hospitals involved in the previous project 
[10], all the 650 tested samples were negative for CMV.
Conclusion and discussion
The range described in the literature for congenital CMV 
is usually low, from 0.2 to 2.2% [1]. However, during the 
current study, a much lower prevalence of CMV congeni-
tal infection was observed (0.078%). This is a significant 
reduction when compared with the historic prevalence 
in Portugal (1.1%) [12] and the results of our previous 
and similar study (0.67%) [10]. Comparing with this late 
study, the strategy/methodology and two of the participant 
hospitals were the same although there were differences 
in length (8 months versus 5 months) and in the season, 
between the 2019 and the 2020 study. However, congeni-
tal CMV has no seasonal distribution or yearly variations 
[14], and therefore these factors must have had minimal, if 
any, impact on the results. Socio-demographic differences 
between the populations of the two studies are another 
possible explanation. However, the initial design of the 
study, aimed to test the pool strategy, did not include the 
analysis of this information.
Despite these potential confounding factors, a plausi-
ble explanation for this significant decrease could be the 
lockdown measures taken in Portugal due to the COVID-19 
pandemic. In March 2020, children stopped attending DCC 
therefore decreasing the probability of CMV transmission to 
their mothers. Despite a progressive return of the children 
to DCC in September 2020, due to the beginning of the new 
school year, the worsening of the pandemic in October led 
many children back home. Thus, during the study period, 
many Portuguese children stayed at home most of the time.
This hypothesis is supported by current knowledge about 
the CMV epidemiology. In fact, it is widely accepted that 
pregnant women frequently acquire cytomegalovirus from 
other children, mainly those attending DCC [6], and recent 
data reinforce the role of young children on the epidemi-
ology of CMV infections [13]. Additional information 
came from two cluster randomised trials and one single-
group study, showing that behavioural measures that reduce 
contact with bodily fluids from young children decreases 
cytomegalovirus seroconversion in pregnant women [3]. 
Although the COVID-19 lockdown measures are obviously 
transitory and therefore without practical application for a 
future prevention strategy, the results of the current study 
are in line with the important role that non-pharmaceutical 
interventions may play in the prevention of the CMV con-
genital infection. However, the current study was not con-
trolled to assess the effect of the lockdown on the incidence 
of congenital CMV infection, and therefore any explanation 
for this reduction remains speculative.
In conclusion, our results showed a significant decrease 
in the prevalence of congenital CMV infection between 
2019 and 2020. The temporal coincidence with COVID-
19 lockdown suggests that these measures may have had a 
significant impact on this reduction, but other explanations 
cannot be excluded. Additional studies are warranted for 
definitive clarification.
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Table 1  Punctual estimative and confidence intervals for both studies 
independently and in comparison between them
a Exact binomial
b Normal distribution
c Based on Newcombe combination method (9)
Punctual estima-
tive (%)
95% Confidence intervals (%)
2019 0.67 (0.32, − 1.23)a
2020 0.078 (0.00, 0.44)a
Comparison 
2020–2019
–0.0059 (−0.01, − 0.002)b
(−0.0012, − 0.0115)c
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